Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal oxycodone bolus dose for postoperative PCIA in elderly patients after laparoscopic gastrointestinal tumor resection
ChiCTR-IPR-15006814Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxycodone in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: VAS score of rest pain and active pain. Started May 2016; status: recruiting.
02
Drugs
oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-15006814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006814.